Edgewise Therapeutics, Inc.’s EWTX share price has surged by 7.97%, which has investors questioning if this is right time to sell.

It was a busy week for the biotech sector, with lots of regulatory and pipeline updates amid fears of a global recession sparked by the ongoing global trade war. Most bigwigs came out with important ...

In this article, we are going to take a look at where Edgewise Therapeutics, Inc. (NASDAQ:EWTX) stands against other stocks ...

Market volatility has not dissuaded some insiders from making big share purchases. The most notable transactions came from ...

Penumbra Inc (NYSE: PEN ): Adam Elsesser, CEO and President, sold shares totaling approximately $4.5 million at prices ranging from $267.36 to $277.63 per share. Elsesser also exercised stock options ...

Shares of Edgewise Therapeutics EWTX plunged 47.7% in a week, likely due to safety concerns for its investigational candidate, EDG-7500, in patients with obstructive or nonobstructive hypertrophic ...

We recently published a list of 10 Unstoppable Stocks That Could Double Your Money. In this article, we are going to take a look at where Edgewise Therapeutics, Inc. (NASDAQ:EWTX) stands against other ...

Piper Sandler reaffirmed their overweight rating on shares of Edgewise Therapeutics (NASDAQ:EWTX – Free Report) in a research ...

Generating significant returns and multiplying their money in the stock market remains a primary goal for most investors.

Fintel reports that on April 3, 2025, Scotiabank downgraded their outlook for Edgewise Therapeutics (NasdaqGS:EWTX) from Sector Outperform to Sector Perform. Analyst Price Forecast Suggests 258.92 ...

Edgewise Therapeutics, Inc.’s EWTX share price has dipped by 15.24%, which has investors questioning if this is right time to ...